default author photo

Kevin R. Flaherty

University of Michigan at Ann Arbor - Department of Internal Medicine

3116 Taubman Center

Ann Arbor, MI 48109-0376

United States

SCHOLARLY PAPERS

1

DOWNLOADS

171

TOTAL CITATIONS

3

Scholarly Papers (1)

1.

Pamrevlumab (FG-3019), an Anti-Connective Tissue Growth Factor Therapy for Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Trial

Number of pages: 30 Posted: 03 May 2019
Catholic University of Milan - Pneumology Complex Operating Unit, National Jewish Health, University of Duisburg-Essen - University Hospital Essen, University of Turin, Columbia University - Mailman School of Public Health, University of Michigan at Ann Arbor - Department of Internal Medicine, St. Luke's Hospital, University of Louisville, University of Utah, MedQIA, FibroGen, Inc., FibroGen, Inc., FibroGen, Inc. - Department of Clinical Development, FibroGen, Inc. - Department of Clinical Development, FibroGen, Inc., FibroGen, Inc. - Department of Clinical Development and University of Washington - Interstitial Lung Disease Clinic
Downloads 171 (440,047)
Citation 3

Abstract:

Loading...